Caitong International Asset Management Co., LTD Dyne Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 3,092 shares of DYN stock, worth $31,291. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,092
Previous 646
378.64%
Holding current value
$31,291
Previous $15.2 Million
112.5%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$105 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$98.3 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$92.4 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$74.8 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $524M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...